Acelyrin Inc. Delists from Nasdaq Following Merger, Becomes Wholly Owned Subsidiary of Alumis

Reuters
05-21
Acelyrin Inc. Delists from Nasdaq Following Merger, Becomes Wholly Owned Subsidiary of Alumis

Acelyrin Inc. announced on May 21, 2025, that it has completed a merger resulting in a change of control, making it a wholly owned subsidiary of Alumis. As part of this transition, Acelyrin notified Nasdaq of the merger's completion and requested the suspension of its common stock trading. The company plans to delist its stock from Nasdaq and deregister under the Securities Exchange Act of 1934. Additionally, Acelyrin intends to terminate its reporting obligations under the Exchange Act. This regulatory change is accompanied by the termination of its 2023 Employee Stock Purchase Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acelyrin Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-123707), on May 21, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10